Dr. Osborne; Gluten Free Warrior
17 October 2011
With the rise in popularity of gluten free diets and gluten sensitivity, the market has adjusted and is diligently working hard to create products and service for those who cannot eat gluten. Currently, the gluten free food market is slated to reach 5 billion plus in annual revenue. Additionally, we have multiple drug companies racing to find solutions. One research group is working on a vaccination for celiac disease.
Here Comes ALV003
Alvine Pharmaceuticals has recently finished a phase 2a trial of ALV003 (a new drug being designed to treat celiac patients). The drug is a modified enzyme with the goal of breaking down gluten based proteins.
Read more: http://www.glutenfreesociety.org/glu...iac-treatment/